From Medscape Diabetes & Endocrinology

Coverage from the

European Association for the Study of Diabetes (EASD) 2018 Annual Meeting

October 01 - 05, 2018; Berlin, Germany

October 01 - 05, 2018 Berlin, Germany

EASD 2018 Nasal Glucagon: Less Fear in Treating Hypoglycemia in Diabetes? Lilly's investigational nasal glucagon was equally effective and safe as the injected formulation in reversing severe hypoglycemia in type 1 diabetes; it may prove simpler to use in stressful situations.
Medscape Medical News, October 22, 2018
EASD 2018 Misdiagnosis of Adult-Onset Type 1 Diabetes Is Common Study finds patients identified with diabetes after age 30 are often misdiagnosed as having type 2 diabetes and not immediately treated with insulin.
Medscape Medical News, October 18, 2018
EASD 2018 Fast Initial Weight Loss May Be Key to Diabetes Prevention A 2-month intensive weight loss program using meal substitutes followed by long-term diet and exercise aimed at weight loss maintenance may help keep type 2 diabetes at bay, finds PREVIEW study.
Medscape Medical News, October 17, 2018

Meeting Highlights At A Glance

Top News From EASD 2018: Slideshow Large postmarketing drug efficacy and safety data plus new consensus guidelines on patient-centered management of type 2 diabetes featured prominently this year.

Conference News

EASD 2018 Nasal Glucagon: Less Fear in Treating Hypoglycemia in Diabetes?
Medscape Medical News, October 22, 2018
EASD 2018 Misdiagnosis of Adult-Onset Type 1 Diabetes Is Common
Medscape Medical News, October 18, 2018
EASD 2018 Fast Initial Weight Loss May Be Key to Diabetes Prevention
Medscape Medical News, October 17, 2018
EASD 2018 Gastric Band, Metformin Equally Prevent Diabetes in Short-Term
Medscape Medical News, October 16, 2018
EASD 2018 Older Women at Risk of Bone, Muscle Loss With Low-Cal Diets
Medscape Medical News, October 12, 2018
EASD 2018 EASE: Empagliflozin Beneficial in Type 1 Diabetes, DKA a Risk
Medscape Medical News, October 11, 2018
EASD 2018 When Does Type 2 Diabetes Start? Changes Evident 20 Years Before
Medscape Medical News, October 10, 2018
EASD 2018 Sweeteners Disrupt Blood Glucose Via Effects on Gut Bacteria
Medscape Medical News, October 9, 2018
EASD 2018 Cutting Carbs in Morning Equals Better Weight Loss, Waist Size
Medscape Medical News, October 9, 2018
EASD 2018 Personalize Diabetes Therapy, New EASD-ADA Guidelines Stress
Medscape Medical News, October 8, 2018

EASD 2018 CARMELINA: Linagliptin Reassures for DPP-4 Inhibitors in Diabetes
Medscape Medical News, October 8, 2018
EASD 2018 More CAMELLIA: Obesity Drug Lorcaserin May Avert Diabetes
Medscape Medical News, October 5, 2018
EASD 2018 Twincretin, a Dual GIP/GLP-1 Agonist, Excites in Type 2 Diabetes
Medscape Medical News, October 4, 2018
EASD 2018 Lixisenatide Renal Benefit in Diabetes With Macroalbuminuria
Medscape Medical News, October 4, 2018
EASD 2018 Insulin at Risk From Variable Temperatures of Home Refrigerators
Medscape Medical News, October 4, 2018
EASD 2018 System Improves Less-Than-Ideally Controlled Type 1 Diabetes
Medscape Medical News, October 3, 2018
EASD 2018 HARMONY: Albiglutide Cuts CV Events but Not Deaths in Diabetes
Medscape Medical News, October 3, 2018
EASD 2018 SGLT2 Inhibitor-Amputation Link in Diabetes -- Is it Hypovolemia?
Medscape Medical News, October 2, 2018
EASD 2018 'Smart' Insoles Reduce Diabetic Foot Ulcer Recurrence
Medscape Medical News, October 2, 2018
EASD 2018 It's Personal: EASD Focuses on Individualizing Diabetes Care
Medscape Medical News, September 24, 2018

Medscape Diabetes© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Expert Commentaries

For the Good of Your Patients, Use SGLT2 Inhibitors
Per-Henrik Groop, MD, DMSc
Put the Focus on Dinner for Blood Sugar Control
Cyrus V. Desouza, MBBS
Plant-Based Diet to Lower Type 2 Diabetes Risk: Is It All or Nothing?
Trudy Voortman, PhD
Oral Semaglutide a 'PIONEER' in the Treatment of T2D
Martin Haluzik, MD, DSc
Be 'Smart' With New Technology for Diabetic Foot Monitoring
Neil D. Reeves, BSc, MSc, PhD
The EASD's President-elect on the 'Pandemic of Diabetes'
Prof David Matthews MA, DPhil, BM, BCh, FRCP, DM
Expert Analysis: New ADA-EASD Guidelines for the Management of Type 2 Diabetes
Prof Simon Heller, BA, MB, Bchir, DM, FRCP
EASD: Flash Monitoring or CGM as a Diagnostic Tool?
Prof Kamlesh KhuntI, MD, PhD
From Film to AI: The Success of Diabetic Eye Screening in England
Prof Peter Scanlon. FRCP FRCOphth FHEA DCH DRCOG DO

Popular News from EASD 2017

EXSCEL: 'Disappointment' Spurs Discussion on GLP-1 Agonists in Diabetes Full details of EXSCEL with the GLP-1 agonist exenatide, in which the agent didn't show any cardiovascular benefit over placebo in type 2 diabetes, provide "some good news" but also "some disappointment."
Medscape Medical News, Sep 14, 2017
CGM in Type 1 Diabetes in Pregnancy Cuts Adverse Neonate Outcomes Pregnant women with type 1 diabetes using continuous glucose monitoring had modestly lower HbA1c and a 50% reduced risk of giving birth to a large-for-gestational-age baby in the CONCEPTT study.
Medscape Medical News, Sep 18, 2017
New Dawn in Diabetes: Apps Can Improve Compliance, With Caveats There's no escaping technology any more when it comes to managing diabetes, from simple apps that help with carb counting to more complex software linking continuous glucose monitors to smartphones.
Medscape Medical News, Oct 06, 2017

Previous Coverage

EASD 2017